世界中医药
文章摘要
引用本文:姚东,胡北,高军,郭晓欢,马宏达,安晔.心脑脉舒口服液质量控制与降血脂作用相关研究[J].世界中医药,2015,10(11):.  
心脑脉舒口服液质量控制与降血脂作用相关研究
Research on the Correlation between the Quality of Xinnao Maishu Oral Solution and its Hypolipidemic Effect
投稿时间:2015-03-19  
DOI:10.3969/j.issn.1673-7202.2015.11.037
中文关键词:  心脑脉舒口服液  羟基红花黄色素A  高效液相色谱法  降血脂
English Keywords:Xinnao Maishu oral solution  Hydroxysafflor A  HPLC  Hypolipidemic
基金项目:军队医疗机构制剂标准提高科研专项课题面上项目(编号:13ZJZ01-3);辽宁省自然科学基金项目(编号:2013020182)
作者单位
姚东,胡北,高军,郭晓欢,马宏达,安晔 沈阳军区总医院药剂科沈阳110016 
摘要点击次数: 1098
全文下载次数: 1287
中文摘要:
      目的:探索心脑脉舒口服液中羟基红花黄色素A含量与高脂血症大鼠降血脂作用的相关性。方法:采用高效液相色谱法建立羟基红花黄色素A含量测定方法,测定高脂血症大鼠血清三酰甘油(Triglyceride,TG)、胆固醇(Cholesterol,TC)、高密度脂蛋白(Highdensitylipoprotein,HDL-C)、低密度脂蛋白(Low Densith Lipoprotein,LDL-C)的含量。结果:羟基红花黄色素A含量测定方法准确性、重复性良好,羟基红花黄色素A的含量与高脂血症大鼠降血脂作用存在一定相关性。结论:羟基红花黄色素A可作为心脑脉舒口服液质量控制指标。
English Summary:
      To explore the correlation between the content of hydroxysafflor A in Xinnao Maishu oral solution and hypolipidemic effect in hyperlipidemia rats. Methods: The content of hydroxysafflor A in Xinnao Maishu oral solution was determined by High Performance Liquid Chromatography(HPLC), and the content of serum cholesterol (TC), triglyceride (TG), low density lipoprotein (LDL-C), high density lipoprotein (HDL-C) in hyperlipidemic rats were determined. Results: The method of hydroxysafflor A content determination is accurate and reproducible. The results showed that there was a certain correlation between the content of hydroxysafflor A and hypolipidemic effect. Conclusion: The content of hydroxysafflor A can be used as the quality control index of Xinnao Maishu oral solution.
查看全文  查看/发表评论  下载PDF阅读器